亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay

药理学 药代动力学 肾脏疾病 药物代谢 药品 医学 肝功能不全 内科学
作者
Yi‐An Bi,Samantha Jordan,Amanda King‐Ahmad,Mark A. West,Manthena V. S. Varma
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:115 (6): 1336-1345 被引量:3
标识
DOI:10.1002/cpt.3215
摘要

Daprodustat is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor approved recently for the treatment of anemia caused by chronic kidney disease (CKD) in adults receiving dialysis. We evaluated the role of organic anion transporting polypeptide (OATP)1B-mediated hepatic uptake transport in the pharmacokinetics (PKs) of daprodustat using in vitro and in vivo studies, and physiologically-based PK (PBPK) modeling of its drug-drug interactions (DDIs) with inhibitor drugs. In vitro, daprodustat showed specific transport by OATP1B1/1B3 in the transfected cell systems and primary human and monkey hepatocytes. A single-dose oral rifampin (OATP1B inhibitor) reduced daprodustat intravenous clearance by a notable 9.9 ± 1.2-fold (P < 0.05) in cynomolgus monkeys. Correspondingly, volume of distribution at steady-state was also reduced by 5.0 ± 1.1-fold, whereas the half-life change was minimal (1.5-fold), corroborating daprodustat hepatic uptake inhibition by rifampin. A PBPK model accounting for OATP1B-CYP2C8 interplay was developed, which well described daprodustat PK and DDIs with gemfibrozil (CYP2C8 and OATP1B inhibitor) and trimethoprim (weak CYP2C8 inhibitor) within 25% error of the observed data in healthy subjects. About 18-fold increase in daprodustat area under the curve (AUC) following gemfibrozil treatment was found to be associated with strong CYP2C8 inhibition and moderate OATP1B inhibition. Moreover, PK modulation in hepatic dysfunction and subjects with CKD, in comparison to healthy control, was well-captured by the model. CYP2C8 and/or OATP1B inhibitor drugs (e.g., gemfibrozil, clopidogrel, rifampin, and cyclosporine) were predicted to perpetrate moderate-to-strong DDIs in healthy subjects, as well as, in target CKD population. Daprodustat can be used as a sensitive CYP2C8 index substrate in the absence of OATP1B modulation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
slayers完成签到 ,获得积分10
30秒前
56秒前
story发布了新的文献求助30
1分钟前
1分钟前
Owen应助光亮雁玉采纳,获得10
1分钟前
SL完成签到,获得积分10
1分钟前
乐乐应助story采纳,获得10
1分钟前
科研通AI5应助光亮雁玉采纳,获得10
1分钟前
1分钟前
爆米花应助光亮雁玉采纳,获得10
1分钟前
Lny发布了新的文献求助20
1分钟前
冰西瓜完成签到 ,获得积分0
1分钟前
科目三应助光亮雁玉采纳,获得10
1分钟前
1分钟前
科研通AI5应助光亮雁玉采纳,获得10
1分钟前
鲁棒的砰砰砰完成签到,获得积分10
2分钟前
2分钟前
Artin发布了新的文献求助30
2分钟前
Ysn发布了新的文献求助10
2分钟前
科研通AI2S应助Ysn采纳,获得10
2分钟前
2分钟前
MchemG应助科研通管家采纳,获得10
3分钟前
MchemG应助科研通管家采纳,获得10
3分钟前
Jim完成签到,获得积分10
3分钟前
3分钟前
puutteita发布了新的文献求助10
3分钟前
wynne313完成签到 ,获得积分10
3分钟前
海妍完成签到,获得积分10
3分钟前
海妍发布了新的文献求助10
3分钟前
我是笨蛋完成签到 ,获得积分10
3分钟前
4分钟前
Artin完成签到,获得积分10
4分钟前
研友_LwlDdn发布了新的文献求助10
4分钟前
nnc发布了新的文献求助50
4分钟前
Weiwei应助nnc采纳,获得50
4分钟前
nnc完成签到,获得积分10
4分钟前
4分钟前
科研通AI2S应助wuran采纳,获得10
4分钟前
顾矜应助科研通管家采纳,获得10
5分钟前
CodeCraft应助科研通管家采纳,获得10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Manipulating the Mouse Embryo: A Laboratory Manual, Fourth Edition 1000
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
Founding Fathers The Shaping of America 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 460
Writing to the Rhythm of Labor Cultural Politics of the Chinese Revolution, 1942–1976 300
Lightning Wires: The Telegraph and China's Technological Modernization, 1860-1890 250
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4569031
求助须知:如何正确求助?哪些是违规求助? 3991376
关于积分的说明 12355741
捐赠科研通 3663539
什么是DOI,文献DOI怎么找? 2018986
邀请新用户注册赠送积分活动 1053396
科研通“疑难数据库(出版商)”最低求助积分说明 940955